Sun Pharma Research Issues Shares To Fund U.S. Paclitaxel Cancer Trials
This article was originally published in PharmAsia News
Executive Summary
A former Sun Pharmaceuticals unit said it would issue additional shares to raise funds for U.S. clinical trials of a version of paclitaxel.